ANTITUMOR COMBINATION OF CHIDAMIDE AND CELECOXIB Russian patent published in 2024 - IPC A61K31/4406 A61K31/415 A61K31/635 A61P35/00 

Abstract RU 2811733 C1

FIELD: medicine, oncology.

SUBSTANCE: group of inventions discloses an antitumor combination containing the acid salt of chidamide and the basic salt of celecoxib, in which the acid salt of chidamide is a hydrochloride or sulfate salt. Also the following is disclosed: a method of regulating the tumor microenvironment during cancer immunotherapy, a method of treating cancer, and a method of treating cancer by regulating the tumor microenvironment and increasing the rate of formation of the immune response.

EFFECT: increase in the rate of formation of the immune response and antitumor activity.

31 cl, 5 tbl, 14 dwg, 10 ex

Similar patents RU2811733C1

Title Year Author Number
COMBINATION OF TRIFLURIDINE/TIPIRACIL HYDROCHLORIDE, ANTITUMOR PLATINUM COMPLEX, AND MODULATOR OF CONTROL POINTS OF IMMUNE RESPONSE 2018
  • Abastado Jean-Pierre
  • Amellal Nadia
  • Bruno Alain
  • Burbridge Michael Frank
  • Cattan Valerie
  • Leger Catherine
RU2778887C2
COMBINATION INCLUDING IMMUNE-STIMULATING OLIGONUCLEOTIDES 2016
  • Shroff Mattyas
  • Shmidt Manuel
  • Kapp Kerstin
  • Tsurlo Alfredo
RU2766693C2
THIOCARBAMATE DERIVATIVES AS A2A INHIBITORS, PHARMACEUTICAL COMPOSITIONS AND COMBINATIONS THEREOF WITH ANTICANCER AGENTS 2019
  • Crosignani, Stefano
  • Dickinson, Paul
  • De Matas, Marcel
  • Houthuys, Erica Joke Katelijne Heleen
  • Marillier, Reece Gerrad
  • Martinoli, Chiara
  • De Henau, Olivier
  • Driessens, Gregory
RU2824502C2
FLUOROVINYLBENZAMIDE COMPOUND AS A PD-L1 IMMUNOMODULATOR 2020
  • Zhang Yang
  • Xia Yuanfeng
  • Sun Deheng
  • Zuo Jian
  • Chen Zhengxia
  • Dai Meibi
  • Li Jian
  • Chen Shuhui
RU2789450C1
IMPROVED THERAPEUTIC INDEX OF INHIBITORS AGAINST IMMUNE CHECKPOINT USING COMBINATION THERAPY INCLUDING PHY906 EXTRACT, SCUTELLARIA BAICALENSIS GEORGI (S) EXTRACT OR COMPOUND OF SUCH EXTRACTS 2017
  • Cheng, Yung-Chi
  • Chen, Lieping
RU2753523C2
NOVEL ANTI-PD-L1 ANTIBODIES 2016
  • Chzhen Yun
  • Li Tszin
  • Chen Chzhishen
RU2736151C2
COMBINATION THERAPY FOR TREATING CANCER WITH POXVIRUS EXPRESSING TUMOUR ANTIGEN AND ANTAGONIST AND/OR AGONIST OF IMMUNE CHECKPOINT INHIBITOR 2014
  • Rauntri, Rajan
  • Foj, Syuzan
  • Mendl, Stefani
  • Delker, Alen
RU2714142C2
NEW APPROACH TO TREATING CANCER WITH APPLICATION OF IMMUNOMODULATION 2016
  • Mehta, Vimal D.
  • Rastelli, Luca
  • Sapra, Aparna Katoch
RU2711380C2
BISPECIFIC ANTIBODIES TO CD25 AND Fc GAMMA-RECEPTOR FOR ELIMINATION OF TUMOR-SPECIFIC CELLS 2017
  • Kezada, Serkhio
  • Peggs, Karl
  • Arse Vargas, Frederik
RU2759970C2
NICOTINYL ALCOHOL ETHER DERIVATIVE MALEATE, ITS CRYSTALLINE FORM AND ITS USE 2020
  • Feng, Zhiqiang
  • Chen, Xiaoguang
  • Ma, Chen
  • Yang, Yang
  • Lai, Fangfang
  • Wang, Yuchen
  • Ji, Ming
  • Guo, Kaijing
RU2816099C1

RU 2 811 733 C1

Authors

Chen, Jia-Shiong

Yang, Mu-Hsuan

Chou, Cheng-Han

Wu, Yi-Hong

Chu, Sz-Hao

Chao, Ye-Su

Chen, Chia-Nan

Dates

2024-01-16Published

2019-09-11Filed